Type
. Infectious complications of human T cell leukemia/lymphoma virus type I infection. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 1996;23(1):138-45.
Type
. The road to the abolition of the leprosy prevention law. Nihon Rai Gakkai zasshi. 1996;65(2):128-35.
Type
. [HLA class II alleles and leprosy (Hansen's disease) classified by WHO-MDT criteria]. Nihon Rai Gakkai zasshi. 1996;65(2):121-7.
Type
. Establishment of mouse cell lines expressing Mycobacterium leprae 65 KDa heat shock protein gene. Nihon Rai Gakkai zasshi. 1996;65(2):113-20.
Type
. A serologic Mycobacteria leprae gelatin particle agglutination (MLPA) in the diagnosis of leprosy: comparison with conventional enzyme-linked immunoassay and bacterial index. Nihon Rai Gakkai zasshi. 1996;65(2):100-5.
Type
. Protein phosphorylation in human peripheral nerve: altered phosphorylation of a 25-kDa glycoprotein in leprosy. Neurochemical research. 1996;21(6):707-12.
Type
. Primary systemic amyloidoses: possible new directions in prophylaxis and therapy. Medical hypotheses. 1996;46(6):505-6.
Type
Progress towards the elimination of leprosy as a public health problem. Weekly epidemiological record [Internet]. 1996;71(20):149-56. Available from: http://www.who.int/docstore/wer/pdf/1996/wer7120.pdf
Type
. Steroid therapy and leprosy. Indian journal of leprosy. 1996;68(2):182-3.
Type
. A leprosy survey in a taluk headquarters town and the role of dermatological services and active health education in its success--a preliminary report. Indian journal of leprosy. 1996;68(2):175-8.